Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2020-02-02 2020-02-02
Drug Identification Number 02463547 02463547
Brand name TARO-DEFERASIROX TARO-DEFERASIROX
Common or Proper name DEFERASIROX DEFERASIROX
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients DEFERASIROX DEFERASIROX
Strength(s) 500MG 500MG
Dosage form(s) TABLET FOR SUSPENSION TABLET FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 30 30
ATC code V03AC V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-01-31 2020-01-31
Remaining supply date 2020-01-31 2020-01-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments